An award-winning small-batch craft cannabis cultivation company (Company A) used genomic data from Medicinal Genomics sequencing to prove another cultivator (Company X) illegally grew their proprietary genetics. Using Genomic Services, they:
You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.
By clicking submit below, you consent to allow Medicinal Genomics Corp to store and process the personal information submitted above to provide you the content requested.
PRIVACY POLICY >
©2024 MEDICINAL GENOMICS CORPS
Copyright all right reserved.
Signup to receive email updates on blog posts, podcasts, webinars, new products, and more!
Join us at the CannMed 24 Innovation and Investment Summit, an exclusive experience of discovery, development, and networking with innovators from around the world.